↓ Skip to main content

MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells

Overview of attention for article published in PLOS ONE, February 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

patent
2 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
219 Dimensions

Readers on

mendeley
150 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
Published in
PLOS ONE, February 2011
DOI 10.1371/journal.pone.0016979
Pubmed ID
Authors

Céline Sabatel, Ludovic Malvaux, Nicolas Bovy, Christophe Deroanne, Vincent Lambert, Maria-Luz Alvarez Gonzalez, Alain Colige, Jean-Marie Rakic, Agnès Noël, Joseph A. Martial, Ingrid Struman

Abstract

MicroRNAs (miRNAs) are endogenously expressed small non-coding RNAs that regulate gene expression at post-transcriptional level. The recent discovery of the involvement of these RNAs in the control of angiogenesis renders them very attractive in the development of new approaches for restoring the angiogenic balance. Whereas miRNA-21 has been demonstrated to be highly expressed in endothelial cells, the potential function of this miRNA in angiogenesis has never been investigated.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Germany 1 <1%
United Kingdom 1 <1%
Belgium 1 <1%
United States 1 <1%
Unknown 145 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 46 31%
Student > Ph. D. Student 26 17%
Student > Master 16 11%
Student > Doctoral Student 12 8%
Student > Bachelor 10 7%
Other 17 11%
Unknown 23 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 57 38%
Biochemistry, Genetics and Molecular Biology 30 20%
Medicine and Dentistry 19 13%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Engineering 3 2%
Other 8 5%
Unknown 28 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2022.
All research outputs
#3,379,754
of 23,371,053 outputs
Outputs from PLOS ONE
#44,460
of 199,880 outputs
Outputs of similar age
#21,086
of 186,614 outputs
Outputs of similar age from PLOS ONE
#311
of 1,271 outputs
Altmetric has tracked 23,371,053 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 199,880 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.3. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,614 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 1,271 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.